Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong
· Delayed Price · Currency is HKD
8.13
+0.12 (1.50%)
Last updated: Mar 10, 2026, 3:10 PM HKT
HKG:2566 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 1,306 | 1,369 | 1,287 | 1,125 | 1,307 |
| Revenue Growth (YoY) | -1.56% | 6.35% | 14.39% | -13.91% | - |
| Cost of Revenue | 239.26 | 287.51 | 296.74 | 271.14 | 356.84 |
| Gross Profit | 1,066 | 1,082 | 990.67 | 854.26 | 950.41 |
| Selling, General & Admin | 808.61 | 808.38 | 723.62 | 649.02 | 686.08 |
| Research & Development | 121.24 | 108.9 | 127.76 | 158.31 | 132.63 |
| Other Operating Expenses | 12.78 | 7.36 | 1.87 | 1.02 | 1.42 |
| Operating Expenses | 942.63 | 924.63 | 853.25 | 808.35 | 820.13 |
| Operating Income | 123.71 | 157.05 | 137.42 | 45.91 | 130.28 |
| Interest Expense | -6.05 | -7.15 | -9.39 | -9.04 | -9.72 |
| Interest & Investment Income | 8.9 | 1.28 | 0.28 | 0.18 | 0.32 |
| Currency Exchange Gain (Loss) | 1.08 | 1.08 | 0.21 | 0.2 | -0.12 |
| Other Non Operating Income (Expenses) | 15.42 | 16.36 | 6.41 | 14.16 | 6.77 |
| Pretax Income | 143.06 | 168.63 | 134.93 | 51.42 | 127.54 |
| Income Tax Expense | 19.63 | 30.03 | 15.16 | -8.45 | 8.12 |
| Net Income | 123.43 | 138.6 | 119.78 | 59.87 | 119.41 |
| Net Income to Common | 123.43 | 138.6 | 119.78 | 59.87 | 119.41 |
| Net Income Growth | -4.14% | 15.72% | 100.07% | -49.87% | - |
| Shares Outstanding (Basic) | 227 | 204 | 200 | 200 | 200 |
| Shares Outstanding (Diluted) | 227 | 204 | 200 | 200 | 200 |
| Shares Change (YoY) | 13.46% | 2.11% | - | - | - |
| EPS (Basic) | 0.54 | 0.68 | 0.60 | 0.30 | 0.60 |
| EPS (Diluted) | 0.54 | 0.68 | 0.60 | 0.30 | 0.60 |
| EPS Growth | -15.52% | 13.32% | 100.07% | -49.87% | - |
| Free Cash Flow | 102.54 | 79.69 | 114.66 | -0.74 | 13.59 |
| Free Cash Flow Per Share | 0.45 | 0.39 | 0.57 | -0.00 | 0.07 |
| Dividend Per Share | 0.056 | 0.056 | - | - | - |
| Gross Margin | 81.67% | 79.00% | 76.95% | 75.91% | 72.70% |
| Operating Margin | 9.47% | 11.47% | 10.67% | 4.08% | 9.97% |
| Profit Margin | 9.45% | 10.12% | 9.30% | 5.32% | 9.13% |
| Free Cash Flow Margin | 7.85% | 5.82% | 8.91% | -0.07% | 1.04% |
| EBITDA | 163.08 | 192.44 | 172.35 | 81.18 | 154.06 |
| EBITDA Margin | 12.49% | 14.06% | 13.39% | 7.21% | 11.79% |
| D&A For EBITDA | 39.37 | 35.39 | 34.93 | 35.27 | 23.78 |
| EBIT | 123.71 | 157.05 | 137.42 | 45.91 | 130.28 |
| EBIT Margin | 9.47% | 11.47% | 10.67% | 4.08% | 9.97% |
| Effective Tax Rate | 13.72% | 17.81% | 11.23% | - | 6.37% |
Source: S&P Capital IQ. Standard template.
Financial Sources.